Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;4(6):1417-22.
doi: 10.2147/vhrm.s2998.

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions

Oyku Gulmez  1 , Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Asli Atar, Alp Aydinalp, Aylin Yildirir, Haldun Muderrisoglu
Affiliations

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions

Oyku Gulmez et al. Vasc Health Risk Manag. 2008.

Abstract

Background: Use of intracoronary calcium channel blockers (CCBs) during percutaneous coronary intervention (PCI) has been shown to have favorable effects on coronary blood flow. We aimed to investigate the effects of CCBs administrated perorally on creatine kinase-MB (CK-MB) levels in patients undergoing elective PCI.

Methods: A total of 570 patients who underwent PCI were evaluated for CK-MB elevation. Patients who were on CCB therapy when admitted to the hospital constituted the CCB group. No CCBs were given to the rest of the patients during the periprocedural period and these patients served as the control group. Blood samples for CK-MB were obtained before and at 6 h, 24 h, and 36 h after the procedure.

Results: 217 patients were in the CCB group (mean age 60.2 +/- 9.3 years, 162 males), and 353 were in the control group (mean age 60.0 +/- 10.1 years, 262 males). CK-MB levels increased above the normal values in 41 patients (18.9%) of the CCBs group and in 97 patients (27.5%) of the control group (p = 0.02). Median CK-MB levels were significantly higher in the control group for all studied hours (for all p < 0.05).

Conclusions: Prior oral CCB therapy may have favorable effects in preventing myocyte necrosis after elective PCI.

Keywords: calcium channel blockers; myonecrosis; percutaneous coronary interventions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean CK-MB levels of the groups during follow-up. Abbreviations: CCB, calcium channel blockers; CK-MB, creatine kinase-MB.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 1996;94:1528–36. - PubMed
    1. Abdelmeguid AE, Topol EJ. The myth of the myocardial ‘infarctlet’ during percutaneous coronary revascularization procedures. Circulation. 1996;94:3369–75. - PubMed
    1. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis. Circulation. 2002;105:554–6. - PubMed
    1. Aronow HD, McRae T, Quinn MJ. Patients on lipid-lowering therapy at the time of myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndrome [abstract] J Am Coll Cardiol. 2002b;39:318A.
    1. Aronow HD, Quinn MJ, Gurm HS. Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy [abstract] J Am Coll Cardiol. 2002a;39:32A.

MeSH terms